论文部分内容阅读
目的:分析舒氨西林治疗肝病并发感染的临床疗效。方法:随机选取72例肝病并发感染患者,按就诊时间分为A、B两组。给予A组患者氨苄西林治疗,给予B组患者舒氨西林治疗,对比两组患者临床治疗效果。结果:A组患者治疗有效率为78.2%;B组患者治疗有效率为95.0%;两组对比差异显著具有统计学意义(P<0.05)。A组不良反应发生率为9.4%,B组不良反应发生率为2.5%。两组对比差异显著具有统计学意义(P<0.05)。结论:舒氨西林治疗肝病并发感染效果显著,安全实效,具有临床应用价值。
Objective: To analyze the clinical effect of sufaxine in the treatment of liver disease complicated with infection. Methods: A total of 72 patients with liver disease were randomly selected and divided into A and B groups according to the time of their visit. Patients in group A were treated with ampicillin, and patients in group B were given sulpiride for comparison. Clinical outcomes were compared between the two groups. Results: The effective rate of treatment in group A was 78.2%. The effective rate of treatment in group B was 95.0%. The difference between the two groups was statistically significant (P <0.05). The incidence of adverse reactions in group A was 9.4%, and the incidence of adverse reactions in group B was 2.5%. The difference between the two groups was statistically significant (P <0.05). CONCLUSIONS: The efficacy of shu-xilin in the treatment of liver disease complicated with infection is significant, safe and effective, and has clinical value.